Sen-Jam Pharmaceutical Inc — Form C-AR (Regulation Crowdfunding)
Sen-Jam Pharmaceutical Inc of Huntington, NY filed a Form C-AR (Regulation Crowdfunding) with the SEC on 2025-04-24.
Offering
- Filed: 2025-04-24
- Form: C-AR
- Accession: 0001670254-25-000415
Issuer
- CIK: 0001802249
- Website: http://sen-jam.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2022-06-15
- Address: 223 Wall Street, #130, Huntington, NY, 11743
- Employees: 5
Financials (as filed)
- Total assets (most recent): $1.3M
- Cash (most recent): $579K
- Net income (most recent): $-4.5M
- Net income (prior): $-4.4M
- Short-term debt: $2.8M
- Long-term debt: $2.2M
People (9)
| Name | Role | Location |
|---|
| Jacqueline Iversen | Chief clinical officer | Huntington, NY |
| Jacqueline Iversen | Chief Clinical Officer | Huntington, NY |
| Jacqueline Iversen | Co-Founder, CCO | Huntington, NY |
| Jacqueline Iversen | Co-Founder, Chief Clinical Officer | Huntington, NY |
| Jacqueline Iversen | Officer | Huntington, NY |
| James Iversen | CEO | Huntington, NY |
| James Iversen | CEO and Director | Huntington, NY |
| James Iversen | CEO & Director | Huntington, NY |
| Jim Iversen | Co-Founder, CEO | LLOYD HARBOR, NY |
Reg CF filing history (16)
More